Abstract
Aims
To assess the burden of type 2 diabetes in Pacific Island countries and predict future trends.
Methods
We analyzed and processed data using R and Excel software, performed Joinpoint 4.7.0 software analysis to investigate changing trends in disease burden, and used an autoregressive integrated moving average model to forecast future trends.
Results
Our study showed that from 1990 to 2019, the burden of type 2 diabetes in Pacific Island countries continues to increase, with the standardized incidence rate showing the most significant growth. Moreover, there were significant differences in the burden of type 2 diabetes between regions. In 2019, American Samoa had the highest standardized incidence rate, while Fiji had the highest standardized death rate and disability-adjusted life year rate. The standardized incidence rate peaked at ages 65–69 years, while the standardized death rate and disability-adjusted life year rate peaked at ages 95 years and 70–74 years respectively. Type 2 diabetes burden was higher among males than females. Based on our forecasting, from 2020 to 2030, the standardized incidence rate is expected to continue to rise, while the standardized death rate and disability-adjusted life year rate will slowly decline.
Conclusions
Our study highlights that the burden of type 2 diabetes in Pacific Island countries has been increasing from 1990 to 2019. Therefore, it is imperative to strengthen disease prevention and control measures in the region.
Publisher
Public Library of Science (PLoS)
Reference55 articles.
1. International Diabetes Federation, Resources, diabetes L, FAQs, Contact, et al. IDF diabetes atlas [Internet]. [cited 2023 May 31]. https://diabetesatlas.org/
2. WHO. Diabetes [Internet]. [cited 2023 Apr 12]. https://www.who.int/news-room/fact-sheets/detail/diabetes
3. Prevalence, Deaths and Disability-Adjusted-Life-Years (DALYs) Due to Type 2 Diabetes and Its Attributable Risk Factors in 204 Countries and Territories, 1990–2019: Results From the Global Burden of Disease Study 2019;S Safiri;Front Endocrinol (Lausanne),2022
4. Burden of Illness in Type 2 Diabetes Mellitus;A Cannon;J Manag Care Spec Pharm,2018
5. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) Study;M Peyrot;Diabet Med,2005